JP2024539138A - 多価効果を持つペプチド - Google Patents

多価効果を持つペプチド Download PDF

Info

Publication number
JP2024539138A
JP2024539138A JP2024523623A JP2024523623A JP2024539138A JP 2024539138 A JP2024539138 A JP 2024539138A JP 2024523623 A JP2024523623 A JP 2024523623A JP 2024523623 A JP2024523623 A JP 2024523623A JP 2024539138 A JP2024539138 A JP 2024539138A
Authority
JP
Japan
Prior art keywords
peptide
amino acids
seq
peptides
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024523623A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024539138A5 (enExample
Inventor
シュミッチェン，アルトゥール
ペットラック，ガンナ
Original Assignee
イントゥーキュア エービー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by イントゥーキュア エービー filed Critical イントゥーキュア エービー
Publication of JP2024539138A publication Critical patent/JP2024539138A/ja
Publication of JP2024539138A5 publication Critical patent/JP2024539138A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2024523623A 2021-10-22 2022-10-21 多価効果を持つペプチド Pending JP2024539138A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21204274.1 2021-10-22
EP21204274 2021-10-22
PCT/EP2022/079429 WO2023067167A1 (en) 2021-10-22 2022-10-21 Peptides with multivalent effects

Publications (2)

Publication Number Publication Date
JP2024539138A true JP2024539138A (ja) 2024-10-28
JP2024539138A5 JP2024539138A5 (enExample) 2025-11-11

Family

ID=78592450

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024523623A Pending JP2024539138A (ja) 2021-10-22 2022-10-21 多価効果を持つペプチド

Country Status (7)

Country Link
US (1) US20250313820A1 (enExample)
EP (1) EP4419664A1 (enExample)
JP (1) JP2024539138A (enExample)
CN (1) CN118202043A (enExample)
AU (1) AU2022369065A1 (enExample)
CA (1) CA3233135A1 (enExample)
WO (1) WO2023067167A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024223868A1 (en) * 2023-04-26 2024-10-31 In2Cure Ab Peptides with multivalent effects for topical use
WO2025051955A1 (en) 2023-09-06 2025-03-13 In2Cure Ab Materials with anti-inflammatory and/or anti-microbial properties

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1987056B1 (en) * 2006-02-10 2012-07-25 Dermagen AB Novel antimicrobial peptides and use thereof
GB0916576D0 (en) * 2009-09-22 2009-10-28 Malmsten Nils M Polypeptides and uses thereof
AU2018304230A1 (en) 2017-07-19 2020-02-06 Dana-Farber Cancer Institute, Inc. Stabilized anti-microbial peptides for the treatment of antibiotic-resistant bacterial infections
JP7785001B2 (ja) * 2019-12-18 2025-12-12 イントゥーキュア エービー トロンビン由来ペプチドを含む組成物およびその使用

Also Published As

Publication number Publication date
US20250313820A1 (en) 2025-10-09
AU2022369065A1 (en) 2024-04-11
WO2023067167A1 (en) 2023-04-27
CN118202043A (zh) 2024-06-14
CA3233135A1 (en) 2023-04-27
EP4419664A1 (en) 2024-08-28

Similar Documents

Publication Publication Date Title
US20240043500A1 (en) Polypeptides and medical uses thereof
RU2468033C2 (ru) Антибактериальные пептиды
US8735353B2 (en) Polypeptides and uses thereof
US20120189673A1 (en) Polypeptides and uses thereof
KR102499670B1 (ko) 라이신 치환을 포함하는 Romo1 유래 항균 펩타이드 및 그 변이체
KR20090027213A (ko) 개선된 항미생물성 펩타이드
JP2024539138A (ja) 多価効果を持つペプチド
ES2475765T3 (es) P�ptido antimicrobiano, formas ramificadas del mismo y su uso en el tratamiento de infecciones bacterianas
WO2025208807A1 (zh) 一种抗菌肽Thanatin衍生肽及其医药用途
Kumar et al. Antibacterial, antibiofilm, and anti-inflammatory effects of a novel thrombin-derived peptide in sepsis models: insights into underlying mechanisms
Shang et al. Engineered peptides harboring cation motifs against multidrug-resistant bacteria
JP4812347B2 (ja) 抗菌性ペプチド
CN112625106A (zh) 一种抗菌多肽化合物、合成方法及其应用
CN115960163A (zh) 抗菌肽、包含抗菌肽的药物组合物及其应用
CA3218327A1 (en) Trem-2/dap-12 inhibitors for treating lung disease and injury and combinations thereof
CN108752433B (zh) 抗微生物肽cramp及其环肽在制备清除细菌生物膜的药物中的应用
WO2008104777A2 (en) Peptide
CN114989246A (zh) Fk3多肽类似物及其应用
KR20030077950A (ko) 생리활성 복합체
WO2008038777A1 (en) Therapeutic agent for disseminated intravascular coagulation syndrome
JP2026504224A (ja) ポリペプチドおよびその使用
Cappiello Effects of two L-to D-amino acid substitutions on the structural and functional properties of the antimicrobial peptide esculentin-1a (1-21)
CN121574193A (zh) 基于fk3的碳硼烷偶联肽及其制备方法和应用
KR20260006472A (ko) 파필리오신 유도체를 유효성분으로 포함하는 패혈증의 예방 또는 치료용 조성물
Schaal et al. Rhesus Macaque Theta Defensins Suppress Inflammatory Cytokines and Enhance Survival in

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251021

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20251021